Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

1.

Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis.

Thorn J, Tilling B, Lisspers K, Jörgensen L, Stenling A, Stratelis G.

Prim Care Respir J. 2012 Jun;21(2):159-66. doi: 10.4104/pcrj.2011.00104.

2.

Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients.

Kruis AL, van Adrichem J, Erkelens MR, Scheepers H, In 't Veen H, Muris JW, Chavannes NH.

Int J Chron Obstruct Pulmon Dis. 2010 Nov 25;5:407-13. doi: 10.2147/COPD.S9654.

3.

[Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care].

Clotet J, Gómez-Arbonés X, Ciria C, Albalad JM.

Arch Bronconeumol. 2004 Apr;40(4):155-9. Spanish.

4.

Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.

Lundgren FL, Cabral MM, Clímaco DC, de Macedo LG, Coelho Mde A, Dias AL.

J Bras Pneumol. 2007 Mar-Apr;33(2):148-51. English, Portuguese.

5.

Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6.

Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W.

Eur Respir J. 2006 Feb;27(2):378-83.

6.

Simplified COPD screening: validation of the PiKo-6® in primary care.

Frith P, Crockett A, Beilby J, Marshall D, Attewell R, Ratnanesan A, Gavagna G.

Prim Care Respir J. 2011 Jun;20(2):190-8, 2 p following 198. doi: 10.4104/pcrj.2011.00040.

7.

Validation of "lung age" measured by spirometry and handy electronic FEV1/FEV6 meter in pulmonary diseases.

Toda R, Hoshino T, Kawayama T, Imaoka H, Sakazaki Y, Tsuda T, Takada S, Kinoshita M, Iwanaga T, Aizawa H.

Intern Med. 2009;48(7):513-21. Epub 2009 Apr 1.

8.

External validation of a COPD diagnostic questionnaire.

Kotz D, Nelemans P, van Schayck CP, Wesseling GJ.

Eur Respir J. 2008 Feb;31(2):298-303. Epub 2007 Oct 24.

9.

Clinical data discriminating between adults with positive and negative results on bronchodilator testing.

Lehmann S, Bakke PS, Eide GE, Gulsvik A.

Int J Tuberc Lung Dis. 2008 Feb;12(2):205-13.

PMID:
18230255
10.

Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry.

Kim JK, Lee CM, Park JY, Kim JH, Park SH, Jang SH, Jung KS, Yoo KH, Park YB, Rhee CK, Kim DK, Hwang YI.

Medicine (Baltimore). 2016 Dec;95(50):e5683.

11.

Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.

Al Ghobain M, Al-Hajjaj MS, Wali SO.

Ann Saudi Med. 2011 Mar-Apr;31(2):129-33. doi: 10.4103/0256-4947.77485.

12.

Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD).

Yu WC, Fu SN, Tai EL, Yeung YC, Kwong KC, Chang Y, Tam CM, Yiu YK.

Int J Chron Obstruct Pulmon Dis. 2013;8:389-95. doi: 10.2147/COPD.S48659. Epub 2013 Aug 26.

13.

Detection of airflow limitation using a handheld spirometer in a primary care setting.

Ching SM, Pang YK, Price D, Cheong AT, Lee PY, Irmi I, Faezah H, Ruhaini I, Chia YC.

Respirology. 2014 Jul;19(5):689-93. doi: 10.1111/resp.12291. Epub 2014 Apr 7.

14.

Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?

Medbø A, Melbye H.

Respir Med. 2007 Jun;101(6):1097-105. Epub 2007 Jan 18.

15.

FEV1/FEV6 in Primary Care Is a Reliable and Easy Method for the Diagnosis of COPD.

Wang S, Gong W, Tian Y, Zhou J.

Respir Care. 2016 Mar;61(3):349-53. doi: 10.4187/respcare.04348. Epub 2015 Nov 3.

16.

The use of microspirometry in detecting lowered FEV1 values in current or former cigarette smokers.

Rytila P, Helin T, Kinnula V.

Prim Care Respir J. 2008 Dec;17(4):232-7. doi: 10.3132/pcrj.2008.00058.

17.

Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?

Kjeldgaard P, Dahl R, Løkke A, Ulrik CS.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 23;10:407-14. doi: 10.2147/COPD.S76047. eCollection 2015 Feb 23.

18.

Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease.

Straus SE, McAlister FA, Sackett DL, Deeks JJ; CARE-COAD2 Group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease..

J Gen Intern Med. 2002 Sep;17(9):684-8.

19.

Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.

Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ.

J Asthma. 2006 Jan-Feb;43(1):75-80.

PMID:
16448970
20.

The FEV1/FEV6 predicts lung function decline in adult smokers.

Enright RL, Connett JE, Bailey WC.

Respir Med. 2002 Jun;96(6):444-9.

PMID:
12117045

Supplemental Content

Support Center